Dane Andreeff, Director at HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT), bought 100,000 shares at $0.56 ($56K) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Open-market purchase of $56k HSDT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.56 | 3,052 | $2K | 3.1% |
| 2 | $0.56 | 11,359 | $6K | 11.4% |
| 3 | $0.56 | 31,620 | $18K | 31.6% |
| 4 | $0.56 | 53,969 | $30K | 54.0% |
| Total | $0.56 avg | 100,000 | $56K | 100% |
| Filing → |
| HSDT | BUY | 2023-08-30 | $71K | — | Filing → |
| HSDT | BUY | 2022-12-19 | $20K | — | Filing → |
| HSDT | BUY | 2022-11-25 | $29K | — | Filing → |